QUALITY-OF-LIFE IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER TREATED WITH CHEMOTHERAPY

[1] ANALYSIS OF SURVIVAL BY TUMOR RESPONSE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) : 710 - 719

[2] VINDESINE, CISPLATIN, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER - SURVIVAL AND QUALITY-OF-LIFE [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (08): : 963 - 970

[3] SICKNESS IMPACT PROFILE - CONCEPTUAL FORMULATION AND METHODOLOGY FOR DEVELOPMENT OF A HEALTH STATUS MEASURE [J]. INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1976, 6 (03): : 393 - 415

[4] Fayers P M, 1983, Stat Med, V2, P429

[5] FAYERS P M, 1985, Cancer Treatment Symposia, V2, P25

[6] HOLMES EC, 1986, CHEST, V89, pS295

[7] KLASTERSKY J, 1986, CHEST, V89, pS289

[8] MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO

[9] 2-W

[10] QUALITY OF SURVIVAL IN PATIENTS WITH SURGICALLY TREATED BRONCHIAL-CARCINOMA [J]. THORAX, 1980, 35 (04) : 255 - 263

[1] ANALYSIS OF SURVIVAL BY TUMOR RESPONSE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) : 710 - 719

[2] VINDESINE, CISPLATIN, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER - SURVIVAL AND QUALITY-OF-LIFE [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (08): : 963 - 970

[3] SICKNESS IMPACT PROFILE - CONCEPTUAL FORMULATION AND METHODOLOGY FOR DEVELOPMENT OF A HEALTH STATUS MEASURE [J]. INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1976, 6 (03): : 393 - 415

[4] Fayers P M, 1983, Stat Med, V2, P429

[5] FAYERS P M, 1985, Cancer Treatment Symposia, V2, P25

[6] HOLMES EC, 1986, CHEST, V89, pS295

[7] KLASTERSKY J, 1986, CHEST, V89, pS289

[8] MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO

[9] 2-W

[10] QUALITY OF SURVIVAL IN PATIENTS WITH SURGICALLY TREATED BRONCHIAL-CARCINOMA [J]. THORAX, 1980, 35 (04) : 255 - 263